GREEN MOUNTAIN STRATEGIES LLC DC

Lobbying for ALVOGEN · Pharmaceutical company developing and manufacturing generic, brand and biosimilar products

Filing 1st Quarter - Report

1st Quarter (Jan 1 - Mar 31) 2025 · New Jersey · House · Senate · $30,000.00 income · posted Apr 21, 2025

Lobbying activity 1

Health Issues

General education regarding pandemic preparedness

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.